Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 3152, May 1, 2008. doi: 10.1158/0008-5472.CAN-07-5348
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Brattain, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Brattain, M. G.

Molecular Biology, Pathobiology, and Genetics

Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells

Jing Wang1, Limin Yang2, Junhua Yang2, Karen Kuropatwinski3, Wang Wang3, Xiao-Qiong Liu1, Jennie Hauser3 and Michael G. Brattain1

1 University of Nebraska Medical Center, Eppley Institute for Research in Cancer and Allied Diseases, Nebraska Medical Center, Omaha, Nebraska; 2 Department of Surgery, University of Texas Health Science Center at San Antonio, San Antonio, Texas; and 3 Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York

Requests for reprints: Michael G. Brattain, University of Nebraska Medical Center, Eppley Institute for Research in Cancer and Allied Diseases, 987696 Nebraska Medical Center, Omaha, NE 68198-7696. Phone: 402-559-4902; Fax: 402-559-3739; E-mail: mbrattain{at}unmc.edu.

Key Words: PI3K • survivin • TGFβ

FET cells, derived from an early-stage colon carcinoma, are nontumorigenic in athymic mice. Stable transfection of a dominant-negative transforming growth factor β (TGFβ) type II receptor (DNRII) into FET cells that express autocrine TGFβ shows loss of TGFβ signaling and increased tumorigenicity in vivo indicating tumor suppressor activity of TGFβ signaling in this model. The ability of tumorigenic cells to withstand growth factor and nutrient deprivation stress (GFDS) is widely regarded as a key attribute for tumor formation and progression. We hypothesized that increased tumorigenicity of FET/DNRII cells was due to loss of participation of autocrine TGFβ in a "fail-safe" mechanism to generate cell death in response to this stress. Here, we document that loss of autocrine TGFβ in FET/DNRII cells resulted in greater endogenous cell survival in response to GFDS due to activation of the phosphoinositide 3-kinase (PI3K)/Akt/survivin pathway. Treatment of FET DNRII cells with a PI3K inhibitor (LY294002) inhibited Akt phosphorylation and reduced survivin expression resulting in increased apoptosis in FET/DNRII cells. We also show that exogenous TGFβ increased apoptosis in FET cells through repression of the PI3K/Akt/survivin pathway during GFDS. These results indicate that the PI3K/Akt/survivin pathway is blocked by TGFβ signaling and that loss of autocrine TGFβ leads to increased cell survival during GFDS through the novel linkage of TGFβ-mediated repression of survivin expression. Inhibition of survivin function by dominant-negative approaches showed that this inhibitor of apoptosis family member is critical to cell survival in the FET/DNRII cells, thus indicating the importance of this target for TGFβ-mediated apoptosis. [Cancer Res 2008;68(9):3152–60]




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Bian, A. Terse, J. Du, B. Hall, A. Molinolo, P. Zhang, W. Chen, K. C. Flanders, J. S. Gutkind, L. M. Wakefield, et al.
Progressive Tumor Formation in Mice with Conditional Deletion of TGF-{beta} Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway
Cancer Res., July 15, 2009; 69(14): 5918 - 5926.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Guha, J. Plescia, I. Leav, J. Li, L. R. Languino, and D. C. Altieri
Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing
Cancer Res., June 15, 2009; 69(12): 4954 - 4958.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Ghoul, M. Serova, L. Astorgues-Xerri, I. Bieche, G. Bousquet, M. Varna, M. Vidaud, E. Phillips, S. Weill, K. A. Benhadji, et al.
Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells
Cancer Res., May 15, 2009; 69(10): 4260 - 4269.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. H. Lee, T. Palaia, and L. Ragolia
Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation
Am J Physiol Cell Physiol, February 1, 2009; 296(2): C327 - C338.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
G. JIANG, B. REN, L. XU, S. SONG, C. ZHU, and F. YE
Survivin May Enhance DNA Double-strand Break Repair Capability by Up-regulating Ku70 in Human KB Cells
Anticancer Res, January 1, 2009; 29(1): 223 - 228.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.